Collado, Beatriz <br/><br/>
Vasoactive intestinal peptide enhances growth and angiogenesis of human experimental prostate cancer in a xenograft model.  [electronic resource] 

 -  Peptides  Sep 2007 
 - 1896-901 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0196-9781 
<br/><br/><label>Standard No.: </label>10.1016/j.peptides.2007.04.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, CD34--metabolism<br/>Cell Line, Tumor<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Hemoglobins--metabolism<br/>Humans<br/>Immunohistochemistry<br/>Male<br/>Mice<br/>Mice, Nude<br/>Neovascularization, Pathologic--pathology<br/>Prostatic Neoplasms--genetics<br/>RNA, Messenger--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Tumor Burden<br/>Vascular Endothelial Growth Factor A--genetics<br/>Vasoactive Intestinal Peptide--pharmacology<br/>Xenograft Model Antitumor Assays--methods